Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iain Stephenson

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Infection|January 4, 2017
Measles - A tale of two sisters, vaccine failure, and the resurgence of an old foeAleem Ahmed, Amandip Sahota, Iain Stephenson, et al.
The Lancet. Infectious Diseases|August 4, 2004
Confronting the avian influenza threat: vaccine development for a potential pandemicIain Stephenson, Karl G Nicholson, John M Wood, et al.
AIDS (London, England)|May 29, 2004
Buschke-Loewenstein lesion: another possible manifestation of immune restoration inflammatory syndrome?Raouf Moussa, Iain Stephenson, Peter Fisk, et al.
The Journal of Infection|September 19, 2017
Cost effectiveness of screening for dengue infection in a UK teaching hospitalJames Veater, Nicholas Wong, Florence Y Lai, et al.
Vaccine|March 18, 2003
Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human populationIain Stephenson, Karl G Nicholson, Anthony Colegate, et al.
Vaccine|April 20, 2010
Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009Iain Stephenson, Frederick Hayden, Albert Osterhaus, et al.
The New England Journal of Medicine|September 12, 2009
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccineTristan W Clark, Manish Pareek, Katja Hoschler, et al.
The Journal of Infectious Diseases|March 19, 2005
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategyIain Stephenson, Roberto Bugarini, Karl G Nicholson, et al.
AIDS (London, England)|August 19, 2022
The impact, effectiveness and outcomes of targeted screening thresholds for programmatic latent tuberculosis infection testing in HIVHelena A White, Rebecca F Baggaley, Hajra Okhai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2009
Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in childrenIain Stephenson, Jane Democratis, Angie Lackenby, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Infection|January 4, 2017
Measles - A tale of two sisters, vaccine failure, and the resurgence of an old foeAleem Ahmed, Amandip Sahota, Iain Stephenson, et al.
The Lancet. Infectious Diseases|August 4, 2004
Confronting the avian influenza threat: vaccine development for a potential pandemicIain Stephenson, Karl G Nicholson, John M Wood, et al.
AIDS (London, England)|May 29, 2004
Buschke-Loewenstein lesion: another possible manifestation of immune restoration inflammatory syndrome?Raouf Moussa, Iain Stephenson, Peter Fisk, et al.
The Journal of Infection|September 19, 2017
Cost effectiveness of screening for dengue infection in a UK teaching hospitalJames Veater, Nicholas Wong, Florence Y Lai, et al.
Vaccine|March 18, 2003
Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human populationIain Stephenson, Karl G Nicholson, Anthony Colegate, et al.
Vaccine|April 20, 2010
Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009Iain Stephenson, Frederick Hayden, Albert Osterhaus, et al.
The New England Journal of Medicine|September 12, 2009
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccineTristan W Clark, Manish Pareek, Katja Hoschler, et al.
The Journal of Infectious Diseases|March 19, 2005
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategyIain Stephenson, Roberto Bugarini, Karl G Nicholson, et al.
AIDS (London, England)|August 19, 2022
The impact, effectiveness and outcomes of targeted screening thresholds for programmatic latent tuberculosis infection testing in HIVHelena A White, Rebecca F Baggaley, Hajra Okhai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2009
Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in childrenIain Stephenson, Jane Democratis, Angie Lackenby, et al.
Pageof 6